Related Experiment Video

Updated: Jan 1, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.8K

MT-MMPs play pivotal roles in cancer dissemination

Ikuo Yana1, Motoharu Seiki

  • 1Division of Cancer Cell Research, Institute of Medical Science, The University of Tokyo, Japan.

Clinical & Experimental Metastasis
|June 18, 2002
PubMed

Insights

Matrix metalloproteinases (MMPs), particularly membrane-type MMPs (MT-MMPs), are vital for cancer cell invasion and spread. Understanding MT-MMP roles in extracellular matrix degradation offers potential new cancer treatments.

Area of Science:

  • Biochemistry
  • Oncology
  • Cell Biology

Background:

  • Matrix metalloproteinases (MMPs) are enzymes involved in extracellular matrix (ECM) remodeling.
  • Membrane-type MMPs (MT-MMPs) are critical regulators of cancer cell invasion and metastasis.
  • Dysregulation of MMPs is implicated in various diseases, including cancer.

Purpose of the Study:

  • To review the current understanding of MT-MMP functions in cancer dissemination.
  • To highlight the role of MT-MMPs in facilitating cancer cell invasion through ECM degradation.
  • To explore potential clinical applications targeting MT-MMPs for cancer treatment.

Main Methods:

  • Literature review of existing research on MT-MMPs and cancer.
  • Analysis of the molecular mechanisms underlying MT-MMP-mediated ECM degradation.
  • Discussion of the interplay between MT-MMPs, cell adhesion, and proteolysis.

Main Results:

  • MT-MMPs orchestrate the localized degradation of the ECM, enabling cancer cell protrusion and invasion.
  • A shift in the balance of cell adhesion molecules and proteolysis at the cell surface promotes cancer cell migration.
  • MT-MMPs are key players in the physiological processes of cancer invasion and migration.

Conclusions:

  • MT-MMPs are essential mediators of cancer cell invasion and dissemination.
  • Further investigation into the molecular environment of tumor-associated MT-MMPs is warranted.
  • Targeting MT-MMPs may offer novel therapeutic strategies for regulating cancer progression.

More Related Videos

Assessing Tumor Microenvironment of Metastasis Doorway-Mediated Vascular Permeability Associated with Cancer Cell Dissemination using Intravital Imaging and Fixed Tissue Analysis09:42

Assessing Tumor Microenvironment of Metastasis Doorway-Mediated Vascular Permeability Associated with Cancer Cell Dissemination using Intravital Imaging and Fixed Tissue Analysis

Published on: June 26, 2019

9.2K
Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior09:44

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior

Published on: June 13, 2016

8.8K

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K